TCP
SGYP

Tourbillon Capital Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Tourbillon Capital Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,147,254
Closed -$18.5M – 100
2017
Q2 		$18.5M Buy
+4,147,254
New +$17.1M 0.59% 50
2016
Q1 		– Sell
-980,931
Closed -$5.56M – 118
2015
Q4 		$5.56M Buy
980,931
+8,194
+0.8% +$50K 0.18% 70
2015
Q3 		$5.16M Buy
972,737
+504,937
+108% +$3.91M 0.2% 82
2015
Q2 		$3.88M Buy
+467,800
New +$2.27M 0.13% 94

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return